PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SUNPHARMA.NS vs. AUROPHARMA.NS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between SUNPHARMA.NS and AUROPHARMA.NS is 0.43, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.4

Performance

SUNPHARMA.NS vs. AUROPHARMA.NS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) and Aurobindo Pharma Limited (AUROPHARMA.NS). The values are adjusted to include any dividend payments, if applicable.

-30.00%-20.00%-10.00%0.00%10.00%SeptemberOctoberNovemberDecember2025February
-6.49%
-28.73%
SUNPHARMA.NS
AUROPHARMA.NS

Key characteristics

Sharpe Ratio

SUNPHARMA.NS:

0.60

AUROPHARMA.NS:

0.29

Sortino Ratio

SUNPHARMA.NS:

0.95

AUROPHARMA.NS:

0.62

Omega Ratio

SUNPHARMA.NS:

1.12

AUROPHARMA.NS:

1.07

Calmar Ratio

SUNPHARMA.NS:

0.84

AUROPHARMA.NS:

0.28

Martin Ratio

SUNPHARMA.NS:

1.90

AUROPHARMA.NS:

0.63

Ulcer Index

SUNPHARMA.NS:

6.09%

AUROPHARMA.NS:

12.53%

Daily Std Dev

SUNPHARMA.NS:

19.21%

AUROPHARMA.NS:

27.47%

Max Drawdown

SUNPHARMA.NS:

-71.46%

AUROPHARMA.NS:

-86.50%

Current Drawdown

SUNPHARMA.NS:

-13.82%

AUROPHARMA.NS:

-28.49%

Fundamentals

Market Cap

SUNPHARMA.NS:

₹4.02T

AUROPHARMA.NS:

₹659.33B

EPS

SUNPHARMA.NS:

₹47.64

AUROPHARMA.NS:

₹59.80

PE Ratio

SUNPHARMA.NS:

35.19

AUROPHARMA.NS:

18.98

Total Revenue (TTM)

SUNPHARMA.NS:

₹513.64B

AUROPHARMA.NS:

₹306.87B

Gross Profit (TTM)

SUNPHARMA.NS:

₹317.10B

AUROPHARMA.NS:

₹151.71B

EBITDA (TTM)

SUNPHARMA.NS:

₹161.31B

AUROPHARMA.NS:

₹67.45B

Returns By Period

In the year-to-date period, SUNPHARMA.NS achieves a -10.97% return, which is significantly higher than AUROPHARMA.NS's -16.04% return. Over the past 10 years, SUNPHARMA.NS has underperformed AUROPHARMA.NS with an annualized return of 7.25%, while AUROPHARMA.NS has yielded a comparatively higher 8.75% annualized return.


SUNPHARMA.NS

YTD

-10.97%

1M

-5.30%

6M

-4.07%

1Y

9.15%

5Y*

34.72%

10Y*

7.25%

AUROPHARMA.NS

YTD

-16.04%

1M

-5.54%

6M

-26.89%

1Y

7.92%

5Y*

14.27%

10Y*

8.75%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SUNPHARMA.NS vs. AUROPHARMA.NS — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SUNPHARMA.NS
The Risk-Adjusted Performance Rank of SUNPHARMA.NS is 6464
Overall Rank
The Sharpe Ratio Rank of SUNPHARMA.NS is 6767
Sharpe Ratio Rank
The Sortino Ratio Rank of SUNPHARMA.NS is 5858
Sortino Ratio Rank
The Omega Ratio Rank of SUNPHARMA.NS is 5656
Omega Ratio Rank
The Calmar Ratio Rank of SUNPHARMA.NS is 7676
Calmar Ratio Rank
The Martin Ratio Rank of SUNPHARMA.NS is 6565
Martin Ratio Rank

AUROPHARMA.NS
The Risk-Adjusted Performance Rank of AUROPHARMA.NS is 5353
Overall Rank
The Sharpe Ratio Rank of AUROPHARMA.NS is 5858
Sharpe Ratio Rank
The Sortino Ratio Rank of AUROPHARMA.NS is 4949
Sortino Ratio Rank
The Omega Ratio Rank of AUROPHARMA.NS is 4646
Omega Ratio Rank
The Calmar Ratio Rank of AUROPHARMA.NS is 6060
Calmar Ratio Rank
The Martin Ratio Rank of AUROPHARMA.NS is 5555
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SUNPHARMA.NS vs. AUROPHARMA.NS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) and Aurobindo Pharma Limited (AUROPHARMA.NS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for SUNPHARMA.NS, currently valued at 0.25, compared to the broader market-2.000.002.000.250.08
The chart of Sortino ratio for SUNPHARMA.NS, currently valued at 0.48, compared to the broader market-4.00-2.000.002.004.006.000.480.33
The chart of Omega ratio for SUNPHARMA.NS, currently valued at 1.06, compared to the broader market0.501.001.502.001.061.04
The chart of Calmar ratio for SUNPHARMA.NS, currently valued at 0.30, compared to the broader market0.002.004.006.000.300.07
The chart of Martin ratio for SUNPHARMA.NS, currently valued at 0.72, compared to the broader market-10.000.0010.0020.0030.000.720.17
SUNPHARMA.NS
AUROPHARMA.NS

The current SUNPHARMA.NS Sharpe Ratio is 0.60, which is higher than the AUROPHARMA.NS Sharpe Ratio of 0.29. The chart below compares the historical Sharpe Ratios of SUNPHARMA.NS and AUROPHARMA.NS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00SeptemberOctoberNovemberDecember2025February
0.25
0.08
SUNPHARMA.NS
AUROPHARMA.NS

Dividends

SUNPHARMA.NS vs. AUROPHARMA.NS - Dividend Comparison

SUNPHARMA.NS's dividend yield for the trailing twelve months is around 0.93%, while AUROPHARMA.NS has not paid dividends to shareholders.


TTM20242023202220212020201920182017201620152014
SUNPHARMA.NS
Sun Pharmaceutical Industries Limited
0.93%0.72%0.91%1.00%0.89%0.68%0.64%0.46%0.61%0.16%0.37%0.18%
AUROPHARMA.NS
Aurobindo Pharma Limited
0.00%0.11%0.55%1.37%0.61%0.46%0.55%0.31%0.40%0.40%0.30%0.29%

Drawdowns

SUNPHARMA.NS vs. AUROPHARMA.NS - Drawdown Comparison

The maximum SUNPHARMA.NS drawdown since its inception was -71.46%, smaller than the maximum AUROPHARMA.NS drawdown of -86.50%. Use the drawdown chart below to compare losses from any high point for SUNPHARMA.NS and AUROPHARMA.NS. For additional features, visit the drawdowns tool.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%SeptemberOctoberNovemberDecember2025February
-15.99%
-30.30%
SUNPHARMA.NS
AUROPHARMA.NS

Volatility

SUNPHARMA.NS vs. AUROPHARMA.NS - Volatility Comparison

The current volatility for Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) is 7.38%, while Aurobindo Pharma Limited (AUROPHARMA.NS) has a volatility of 11.33%. This indicates that SUNPHARMA.NS experiences smaller price fluctuations and is considered to be less risky than AUROPHARMA.NS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%SeptemberOctoberNovemberDecember2025February
7.38%
11.33%
SUNPHARMA.NS
AUROPHARMA.NS

Financials

SUNPHARMA.NS vs. AUROPHARMA.NS - Financials Comparison

This section allows you to compare key financial metrics between Sun Pharmaceutical Industries Limited and Aurobindo Pharma Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in INR except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab